Stay updated on Satralizumab in Generalized Myasthenia Gravis Clinical Trial

Sign up to get notified when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The Italy location entry was updated from Napoli, Campania, 80131 to Naples, Campania, 80131. The page revision label changed from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T00:21:19.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2. This appears to be a small administrative update with no changes to study details.
    Difference
    0.0%
    Check dated 2026-03-06T15:53:38.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Results have been posted for the study and the status updated to Terminated; the page now reflects the published outcomes.
    Difference
    0.0%
    Check dated 2026-02-27T12:29:31.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1 on the page.
    Difference
    0.0%
    Check dated 2026-02-12T15:54:12.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and v3.4.0 was removed; this appears to be an administrative update with no visible impact on the study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T11:27:06.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    Added a glossary display, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and revision label v3.4.0; removed Last Update Submitted that met QC Criteria, No FEAR Act data, and revision label v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-29T04:53:45.000Z thumbnail image

Stay in the know with updates to Satralizumab in Generalized Myasthenia Gravis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Satralizumab in Generalized Myasthenia Gravis Clinical Trial page.